logo-loader
viewSocial Reality, Inc.

Srax enjoys influx of cash after sale of SRAXmd of 52.5 million

SRAX (OTCQB:SCRI) CEO Chris Miglino joined Proactive Investors in San Francisco to talk about some major news about the company involving the sale of SRAXmd.

Miglino also talked about how the revenue from that sale will move the company forward as they get set to help to utilize blockchain technology for the BIGtoken platform

Quick facts: Social Reality, Inc.

Price: 2.035 USD

NASDAQ:SRAX
Market: NASDAQ
Market Cap: $28.56 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Algernon Pharmaceuticals receives US FDA clearance for Phase 2b/3 human study

Algernon Pharmaceuticals Inc. (CSE: AGN-OTCQB: AGNPF) CEO Christopher Moreau joined Steve Darling from Proactive Vancouver with major news for the company that they have received clearance from the U.S. FDA for its multinational Phase 2b/3 study of Ifenprodil as a potential treatment for...

29 minutes ago

2 min read